SAGALIUM RESPONDS TO COMPETITOR'S FALSE AND MISLEADING PRESS RELEASE

Forward Looking Statements Barry Kostiner, the CEO of Sagaliam, commented, "Virogentics, Inc. holds the exclusive worldwide license for ITV-1 and is the sole owner of the trade secrets needed to produce the treatment. The statements in the NIKA press release are incorrect and have no foundation in truth. After numerous failed attempts by Mr. Savov to make a claim of ownership to the patents owned by the Zhabilov Trust or any other association with ITV-1, it appears that he has now taken to making unfounded ...